Leveraging Value Added Data For Clinical Data Review In DMW
Blog
  • Topics
  • Industries
  • Partners

Explore

Topics

Industries

Partners

Leveraging Value Added Data For Clinical Data Review In DMW

In my previous post, we discussed a simple scenario for reviewing clinical data cleanliness in Oracle’s Data Management Workbench. Today, we’ll discuss a similar process, although this scenario leverages value added data.

Clinical/Medical Monitor Review of data from DMW with Value Added Data

Establishing value added data is another way to help the clinician to more quickly review the data and spot outliers and questionable data. This value added data may include the following short list of examples:

  • MedDRA categorization of adverse events and drug thesauruses data for drug treatment
  • % change since baseline across visit evaluations
  • Unit Conversion/Standardization
  • Therapeutic area/study specific derivations or imputations based upon data within one evaluation or across multiple records of clinical data
  • Statistical measures/confidence intervals

This derived data can help spot potential issues more quickly than only reviewing the raw source data.

The subject of using data models in DMW will be discussed in an upcoming post, where I will dig deeper into how data models can be used to support value added data.

In the meantime, if you are interested in learning how my team can help you leverage value added data in your clinical data review process, please send us an email.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the Weekly Blog Digest:

Sign Up

Categories